
    
      Two hundred non-randomized subjects will participate in the study at up to ten clinical sites
      in the United States. Participants will be between 18 and 75 years of age. All subjects will
      have been established with lumbar spine disease at one or two levels of the lumbar spine that
      requires lumbar interbody fusion procedure as per the opinion of the treating surgeon. The
      diseases included in the study are spondylosis, degenerative disc disease and
      spondylolisthesis. All subjects who meet the inclusion criteria and do not meet the exclusion
      criteria and who elect to participate and sign the informed consent will be included in the
      study.
    
  